Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2000
02/03/2000WO2000005387A1 Chorismate biosynthesis enzymes
02/03/2000WO2000005386A2 Chorismate biosynthesis enzymes
02/03/2000WO2000005380A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization
02/03/2000WO2000005375A1 Gbs toxin receptor
02/03/2000WO2000005370A1 Orphan cytokine receptor
02/03/2000WO2000005367A2 Human proteins having hydrophobic domains and dnas encoding these proteins
02/03/2000WO2000005365A1 Human lcb kinase 1
02/03/2000WO2000005364A1 Protein similar to neuroendrocrine-specific protein, and encoding cdna
02/03/2000WO2000005363A1 Method for screening of modulators of calcineurin activity
02/03/2000WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1)
02/03/2000WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors
02/03/2000WO2000005353A2 Chorismate synthase from plants
02/03/2000WO2000005348A1 Pneumococcal nrdg protein
02/03/2000WO2000005316A1 Coating of solid surfaces with activated polyhydroxypolymers
02/03/2000WO2000005267A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use
02/03/2000WO2000005266A1 Anti hepatitis c virus antibody and uses thereof
02/03/2000WO2000005265A2 Anti-crr2 antibodies and methods of use therefor
02/03/2000WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6)
02/03/2000WO2000005256A1 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
02/03/2000WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases
02/03/2000WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
02/03/2000WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
02/03/2000WO2000004923A1 Scrp-5: secreted cysteine rich protein-5
02/03/2000WO2000004893A2 Imidazoline receptor binding compounds
02/03/2000WO2000004868A2 Libraries of polyhydroxamates and their analogs
02/03/2000WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
02/03/2000WO2000004821A1 Fluid management in a continuous fluid collection and sensor device
02/03/2000WO2000004760A1 Copper transporter in ethylene signaling pathway
02/03/2000WO1999067425A3 Binding acceleration techniques for the detection of analytes
02/03/2000WO1999066780A3 Cinoxacin lanthanide chelates and their use as biomolecular probes
02/03/2000WO1999064561A3 Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999063932A3 Multibinding agents that modulate the 5-ht transporter
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
02/03/2000WO1999061052A3 Oral immunization with papillomavirus virus-like particles
02/03/2000WO1999060120A3 Soluble t cell receptor
02/03/2000WO1999060119A3 Multivalent t cell receptor complexes
02/03/2000WO1999059620A9 Angiostatin receptor
02/03/2000WO1999058947A3 Modulation of molecular interaction sites on rna and other biomolecules
02/03/2000WO1999058474A9 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds
02/03/2000WO1999057546A9 An instrument and method for measurement of stability of oils
02/03/2000WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
02/03/2000WO1999052945A9 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
02/03/2000WO1999051773A9 Addressable protein arrays
02/03/2000WO1999045384A8 Determination of white blood cell differential and reticulocyte counts
02/03/2000WO1999037783A3 Live vaccine against brucellosis
02/03/2000DE19928456A1 Verfahren zur Bestimmung der räumlichen Struktur von Graphit in Gußeisen A method for determining the spatial structure of graphite in cast iron
02/03/2000DE19847779C1 Novel receptor DNA useful for identifying apoptosis-modulating substances potentially useful for cancer chemotherapy
02/03/2000DE19836090A1 Avian vitelline antibody directed against soil urease useful for quantifying urease in the soil by immunoassay
02/03/2000DE19836084A1 Avian vitelline antibody against ammonifying microorganisms, especially soil bacterium W7/15, useful for quantifying ammonifying microorganisms in the soil by immunoassay
02/03/2000DE19834766A1 Combination of analytical information obtained from chemical sensor devices and an analytical apparatus, e.g. mass spectrometer
02/03/2000DE19834184A1 Verfahren und Vorrichtung zur Optimierung von Lacken Method and apparatus for optimizing coatings
02/03/2000DE19833738A1 Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens A method for isolating cancer cells from cell-containing body fluids, and kits for carrying out this method
02/03/2000DE19833683A1 Selective deposition, e.g. for conductive polymer coating or micro-manipulation, comprises selectively irradiating substrate with light-dependent electrical properties in solution of substance which precipitates in an electric field
02/03/2000DE19832900A1 Streichfarbe und gestrichenes Papier mit einer aus der Streichfarbe gebildeten Beschichtung zur Fälschungssicherung von Formularen Coating color and coated paper with a layer formed of the coating color coating for anti-counterfeiting forms
02/03/2000DE19832344A1 Concrete bridge carriageway or magnetic railtrack part is checked for cracks via formed test channels close-spaced near part top for gas or fluid test runs.
02/03/2000DE19831947A1 Laboratory pilot filtration rig for predicting filterability and filter-aid dosing requirements for bulk liquids, such as beer and wine
02/03/2000DE19831946A1 Laboratory pilot filtration rig for predicting filterability and filter-aid dosing requirements for bulk liquids, such as beer and wine
02/03/2000DE19831758A1 Ligandenbestimmung für Proteine Ligands for proteins determination
02/03/2000DE19830709A1 Meßwandler zur Detektion von Kohlenwasserstoffen in Gasen Transducer for detecting hydrocarbon gases in
02/03/2000CA2339045A1 Anti hepatitis c virus antibody and uses thereof
02/03/2000CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
02/03/2000CA2338456A1 Assembly and apparatus for extracellular electrophysiological recordings and their use
02/03/2000CA2338401A1 Optical disc-based assay devices and methods
02/03/2000CA2338312A1 A subfamily of rna helicases wich are modulators of the fidelity of translation termination and uses thereof
02/03/2000CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
02/03/2000CA2338292A1 Fluid management in a continuous fluid collection and sensor device
02/03/2000CA2338279A1 Imidazoline receptor binding compounds
02/03/2000CA2338270A1 Method for manufacturing a carrier for chemical or biochemical assays
02/03/2000CA2338269A1 Coating of solid surfaces with activated polyhydroxypolymers
02/03/2000CA2338259A1 Portable immediate response medical analyzer having multiple testing modules
02/03/2000CA2338205A1 Method
02/03/2000CA2337756A1 Libraries of polyhydroxamates and their analogs
02/03/2000CA2337415A1 Agglutination assays
02/03/2000CA2337153A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination
02/03/2000CA2337027A1 Paint and paper coated with said paint
02/03/2000CA2336487A1 Copper transporter in ethylene signaling pathway
02/03/2000CA2336250A1 Anti-ccr2 antibodies and methods of use therefor
02/03/2000CA2336225A1 Human proteins having hydrophobic domains and dnas encoding these proteins
02/03/2000CA2335646A1 Genes of the dead box protein family, their expression products and use
02/03/2000CA2335345A1 Human calcium regulatory proteins
02/03/2000CA2335343A1 Novel methods for the identification of ligand and target biomolecules
02/03/2000CA2335278A1 Method for screening of modulators of calcineurin activity
02/03/2000CA2335276A1 Nucleic acid detection method by triple helix formation
02/03/2000CA2334947A1 Novel peptides for use in immunotherapy of autoimmune diseases
02/03/2000CA2334042A1 Orphan cytokine receptor
02/03/2000CA2333302A1 Antibodies for the dectection of beer spoilage lactic acid bacteria, method of detection using the antibodies, and kit employing the antibodies
02/03/2000CA2332487A1 Quantitative analysis of gene expression using pcr
02/03/2000CA2303855A1 Multiple analyte assay device
02/02/2000EP0977037A1 Magnetic separator
02/02/2000EP0977036A1 METHOD FOR ASSAYING AGALACTO-IgG AND ASSAY KITS, POLYPEPTIDES OF LECTINS, AND DNAS ENCODING THE SAME
02/02/2000EP0977035A2 A system for determining the electrical potential across a membrane
02/02/2000EP0977034A2 Transparent flow through membrane for dry reagent analytical devices
02/02/2000EP0977033A2 Method and test kit for determining the cosmetic tanning potential of a self-tanning composition
02/02/2000EP0976836A1 Digital hybridization screening
02/02/2000EP0976834A2 Liquid reagent for calcium assay
02/02/2000EP0976825A1 Transcriptional regulator
02/02/2000EP0976823A1 Recombinant expression system and high throughput BioAssay for the therapeutic use of calcineurine-A- alpha, calcineurine-A-beta, calcineurine-A-gamma, calcineurine-B und Cu/Zn-superoxide dismutase respectively for the identification of pharmaceuticals
02/02/2000EP0976763A1 Antigens and immunoassays for diagnosing Chagas' disease
1 ... 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 ... 3937